N-(2-hydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline-1-carboxamide

ID: ALA4877951

PubChem CID: 64366482

Max Phase: Preclinical

Molecular Formula: C16H16N2O2

Molecular Weight: 268.32

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccccc1O)C1NCCc2ccccc21

Standard InChI:  InChI=1S/C16H16N2O2/c19-14-8-4-3-7-13(14)18-16(20)15-12-6-2-1-5-11(12)9-10-17-15/h1-8,15,17,19H,9-10H2,(H,18,20)

Standard InChI Key:  OOBOWDHUFYTQJA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.2491  -16.9876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2480  -17.8072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9560  -18.2161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9542  -16.5788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6629  -16.9840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6636  -17.8031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3722  -18.2101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0804  -17.7993    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0757  -16.9772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3666  -16.5738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3739  -19.0273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6670  -19.4374    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0824  -19.4344    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6687  -20.2546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9602  -20.6595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9616  -21.4759    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6706  -21.8839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3798  -21.4694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3750  -20.6543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0797  -20.2406    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  5  1  0
  7 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 19 20  1  0
M  END

Associated Targets(Human)

NUGC-3 (976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 268.32Molecular Weight (Monoisotopic): 268.1212AlogP: 2.22#Rotatable Bonds: 2
Polar Surface Area: 61.36Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 8.80CX Basic pKa: 7.51CX LogP: 2.20CX LogD: 2.00
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.73Np Likeness Score: -0.30

References

1. Sim S, Lee S, Ko S, Phuong Bui B, Linh Nguyen P, Cho J, Lee K, Kang JS, Jung JK, Lee H..  (2021)  Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway.,  46  [PMID:34500188] [10.1016/j.bmc.2021.116371]

Source